Denali Therapeutics · 6 hours ago
Intern, Global Business Insights & Operations
South San Francisco, CA
Internship
Onsite
Intern
$136K/yr - $136K/yr
Start in 2026 SummerDenali Therapeutics is a biotechnology company dedicated to developing breakthrough therapies for neurodegenerative diseases. The internship position in Global Business Insights & Operations focuses on supporting projects that bridge global commercialization insights and commercial operations excellence.
BiotechnologyGeneticsHealth DiagnosticsTherapeutics
Responsibilities
Conduct secondary research and data analysis to characterize the global commercialization landscape for one or more of Denali’s key assets, including market dynamics, competitive activity, access considerations, and patient/caregiver insights
Support the synthesis of research findings into clear, actionable insights that inform commercial strategy
Partner with members of the Global Business Insights and Commercial Operations teams to improve internal tools, reporting processes, and/or operational workflows that support commercial effectiveness and decision-making during early launch window of tividenofusp alfa
Contribute to the design and execution of key deliverables (e.g., market landscape summaries, dashboards, or process improvement proposals)
Present findings to cross-functional stakeholders at the end of the internship
Qualification
Required
Candidates should currently be enrolled & pursuing a Master of Business Administration (MBA)
Self- and results-driven, organized, resourceful, adaptable and collaborative
Bold and creative thinker with a curious nature, eager to learn about the complexities of the business of healthcare and biotech
Evident communication and analytical skills
High degree of proficiency with the MS Office Suite or Google equivalent
Preferred
Undergraduate BA/BS in Health Sciences, Business / Economics or related discipline
Manifested interest in the healthcare industry or biopharma
Benefits
Paid holiday time off is based on Denali's designated holidays.
Interns who live more than 50 miles away from the office are eligible for an additional housing stipend.
Company
Denali Therapeutics
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
Founded in 2013
501-1000 employees
H1B Sponsorship
Denali Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (10)
2024 (14)
2023 (7)
2022 (6)
2021 (5)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$1.32BKey Investors
Royalty PharmaBaillie Gifford
2025-12-04Post Ipo Debt· $200M
2024-02-27Post Ipo Equity· $500M
2022-10-19Post Ipo Equity· $275M
Leadership Team
Ryan Watts
CEO
Peter Chin
Sr. Vice President & Head of Late-Stage Clinical Development and Medical Affairs
Recent News
The Motley Fool
2025-12-11
2025-12-11
MarketScreener
2025-12-10
Company data provided by crunchbase